2,5-Dimethoxy-4-ethoxyamphetamine

MEM
Clinical data
Other names2,5-Dimethoxy-4-ethoxyamphetamine; 4-Ethoxy-2,5-dimethoxyamphetamine; MEM
Routes of
administration
Oral
Drug classSerotonin receptor agonist; Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
Legal status
Legal status
Pharmacokinetic data
Elimination half-life10–14 hours
Identifiers
  • 1-[(4-ethoxy-2,5-dimethoxy)phenyl]propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H21NO3
Molar mass239.315 g·mol−1
3D model (JSmol)
  • O(c1cc(OC)c(cc1OC)CC(N)C)CC
  • InChI=1S/C13H21NO3/c1-5-17-13-8-11(15-3)10(6-9(2)14)7-12(13)16-4/h7-9H,5-6,14H2,1-4H3 Y
  • Key:ITZLAXJQDMGDEO-UHFFFAOYSA-N Y
  (verify)

2,5-Dimethoxy-4-ethoxyamphetamine (MEM) is a psychedelic drug of the phenethylamine, amphetamine, and DOx families. It was first described by Alexander Shulgin by 1968.